News & Updates

Stay informed about the latest developments in AI-powered cardiovascular care and HeartSciences company news.

HeartSciences Receives FDA Clearance for Enhanced AI Algorithm Suite

The expanded clearance includes new algorithms for detection of hypertrophic cardiomyopathy and long QT syndrome, bringing our total to 12 validated conditions.

Clinical

December 8, 2023

New Multi-Center Study Validates AI-ECG Detection of Diastolic Dysfunction

Results from 12 medical centers demonstrate 87% sensitivity for detecting early-stage diastolic dysfunction in a diverse patient population.

Partnership

November 22, 2023

HeartSciences Partners with Leading Health System for Enterprise Deployment

The partnership will bring AI-powered ECG analysis to over 200 clinical sites across the Midwest region, transforming cardiovascular screening.

Product

October 5, 2023

MyoVista Insights 2.0 Released with Enhanced Reporting Features

The latest version includes improved clinical reports, population health dashboards, and deeper EHR integration capabilities.

Regulatory

September 18, 2023

HeartSciences Expands into European Markets with CE Marking

Following successful regulatory approval, HeartSciences is now available to healthcare providers across the European Union.

Clinical

August 12, 2023

Study Published in Circulation Validates Primary Care Use Case

Prospective evaluation in 45 primary care clinics shows significant improvement in cardiac abnormality detection with minimal workflow impact.

Company

July 28, 2023

HeartSciences Raises $50M Series C to Accelerate Global Expansion

Funding will support international growth, expanded clinical research, and new algorithm development for additional cardiac conditions.

Product

June 15, 2023

New Integration with Epic EHR Streamlines Clinical Workflow

Direct integration enables seamless ordering, results delivery, and billing within Epic-based healthcare systems.